Browsing by Author "Yildirim, B. Akkus"
Now showing 1 - 15 of 15
- Results Per Page
- Sort Options
Item Adjuvant Radiotherapy in Cervical Cancer Patients: TROD Gynecologic Group Study(2020) Gultekin, M.; Esen, C. S. Beduk; Balci, B.; Alanyali, S.; Yildirim, B. Akkus; Ergen, S. A.; Sahinler, I.; Cetin, I. Alsan; Onal, C.; Yildiz, F.; Ozsaran, Z.; 0000-0002-2742-9021; D-5195-2014Item The Correlation Between FDG-PET Parameters and Hematologic Parameters in Patients with Esophageal Squamous-Cell Carcinoma Treated with Definitive Chemoradiotherapy(2017) Yildirim, B. Akkus; Onal, C.; Torun, N.; Ozdemir, Y.; Guler, O. C.; 0000-0001-6661-4185; 0000-0002-5597-676X; 0000-0002-2218-2074; 0000-0001-6908-3412; V-5717-2017; HOC-5611-2023; AAE-2718-2021; AAG-5629-2021; AAC-5654-2020Item Dosimetric Comparison of 3-Dimensional Conformal Radiotherapy, Volumetric Modulated ARC Therapy, and Helical Tomotherapy for Postoperative Gastric Cancer Patients(2017) Onal, C.; Dolek, Y.; Yildirim, B. Akkus; 0000-0001-6661-4185; HOC-5611-2023; V-5717-2017Item Dosimetric Comparison of Simultaneous-Integrated BOOST and Sequential BOOST with VMAT or Helical Tomotherapy in Breast Cancer Patients after Breast-Conserving Surgery(2019) Onal, C.; Efe, E.; Yildirim, B. Akkus; Guler, O. C.; 0000-0001-6908-3412; AAC-5654-2020Item Dosimetric Comparison of Stereotactic Body Radiation Therapy Plans With Volumetric Arc Therapy, Helical Tomotherapy, and Raystation for Liver Metastasis(2017) Onal, C.; Efe, E.; Yildirim, B. Akkus; 0000-0001-6661-4185; HOC-5611-2023; V-5717-2017Item The Hematologic Changes During Treatment In Cervical Cancer Patients Treated With Chemoradiotherapy(2018) Yildirim, B. Akkus; Onal, C.; Kose, F.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item The Impact of Tumor Volume in Breast Cancer Liver Metastasis Patients Treated with Stereotactic Radiotherapy - Does Size Matter?(2020) Guler, O. C.; Yildirim, B. Akkus; Onal, C.; 0000-0002-2742-9021; 0000-0001-6908-3412; D-5195-2014; AAC-5654-2020Item The Importance of Prognostic Nutritional Index in Cervical Cancer Patients Treated with Concomitant Chemoradiotherapy(2017) Yildirim, B. Akkus; Guler, O. C.; Onal, C.; 0000-0001-6661-4185; 0000-0001-6908-3412; V-5717-2017; AAC-5654-2020; HOC-5611-2023Item Multi-institutional review of SBRT for adrenal metastasis: Turkish Radiation Oncology Society Study(2022) Elmali, A.; Yildirim, B. Akkus; Cengiz, M.; Sari, S. Yuce; Onal, H. C.; Berber, T.; Erken, A. Arslantas; Mustafayev, T. Zoto; Atalar, B.; Unal, IItem Prognostic Utility of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiation Therapy for Cervical Cancer(2016) Onal, C.; Guler, O. C.; Yildirim, B. Akkus; 0000-0001-6908-3412; 0000-0001-6661-4185; HOC-5611-2023; AAC-5654-2020; V-5717-2017Item Radiation Therapy Outcomes After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction(2016) Sari, S. Yuce; Kotek, A.; Gultekin, M.; Yildirim, B. Akkus; Onal, C.; Ozyigit, G.; Gurkaynak, M.; Yildiz, F.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item The Treatment Outcomes of Oligometastatic Colorectal Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Multi-Institutional Analysis TROD 02-008(2022) Guler, O. C.; Hurmuz, P.; Atalar, B.; Guney, Y. Yukselen; Saglam, E. K.; Akyurek, S.; Bolukbasi, Y.; Gural, Z.; Tugrul, F.; Korcum, A. F.; Sen, C. A.; Yildirim, B. Akkus; Oksuz, D. C.; Celik, O. Karakoyun; Kurt, M.; Guzeloz, Z.; Yavas, G.; Ozyigit, G.; Aksu, M. G.; Onal, C.; 0000-0001-9724-253X; 0000-0003-1043-8105; GNH-4101-2022; G-9920-2016Item The Treatment Outcomes of Patients with Cervical Esophageal Carcinoma Undergoing Definitive Chemoradiotherapy: A Multi-Institutional Analysis TROD 01-005(2022) Guler, O. C.; Oymak, E.; Yazici, G.; Akagunduz, O. Ozkaya; Cetinayak, O; Erpolat, P.; Aksoy, A.; Duzova, M.; Yildirim, B. Akkus; Kurt, M.; Canyilmaz, E.; Akyurek, S.; Atalar, B.; Yavas, G.; Oksuz, D. C.; Saglam, E. K.; Celik, O. Karakoyun; Cengiz, M.; Onal, C.; 0000-0002-5399-5430; AAA-1349-2022Item The Utility of Dissected Lymph Node Number and Lymph Node Metastasis Ratio In Stage IIIC Endometrium Adenocarcinoma: A Multicentric Analysis(2018) Yildirim, B. Akkus; Onal, C.; Sari, S. Yuce; Yavas, G.; Gultekin, M.; Guler, O. C.; Yildiz, F.; Akyurek, S.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging(2019) Gultekin, M.; Guler, O. C.; Sari, S. Yuce; Yildirim, B. Akkus; Mustafayev, T. Z.; Atalar, B.; Bolukbasi, Y.; Onal, H. C.; Celik, H.; Yuce, K.; Ayhan, A.; Yildiz, F.; 0000-0001-6908-3412; AAC-5654-2020